Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.61 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.56 |
| ▸ | CCR6 | P51684 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.56 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.52 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.52 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 2/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8189337 | 0.91 | CYP2A6 (0.73) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| Benzaldehyde SCHEMBL28191631 | 0.83 | CYP2A6 (0.83) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL11843859 | 0.83 | CYP2A6 (0.70) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL28032989 | 0.82 | ALDH1A1 (0.59) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL851178 | 0.82 | ALDH1A1 (0.59) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL2199745 | 0.82 | ALDH1A1 (0.59) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL181026 | 0.82 | ALDH1A1 (0.59) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL13649928 | 0.82 | ALDH1A1 (0.59) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL7693616 | 0.82 | CYP2A6 (0.73) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL18002478 | 0.82 | ALDH1A1 (0.48) | CYP2A6CYP2A13ALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3197396-A | — | — | None | — | — | JP | disclosed |
| US-20250011264-A1 | CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND | SUMITOMO BAKELITE CO., LTD. (JP) | 2025-01-09 | — | — | US | disclosed |
| EP-4434960-A1 | CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND | Sumitomo Bakelite Co., Ltd. (JP) | 2024-09-25 | — | — | EP | disclosed |
| CN-118265685-A | Cyclic compound and method for producing cyclic compound | 住友电木株式会社 | 2024-06-28 | — | — | CN | disclosed |
| WO-2023090298-A1 | CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND | 住友ベークライト株式会社 | 2023-05-25 | — | — | WO | disclosed |
| EP-3246317-B1 | BTK INHIBITOR | HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC (CN) | 2023-02-22 | — | — | EP | disclosed |
| US-10662174-B2 | BTK inhibitor | HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECHNOLOGICAL INSTITUTE, INC. (CN) | 2020-05-26 | — | — | US | disclosed |
| EP-3184448-B1 | MULTILAYER PLASTIC CONTAINER | MITSUBISHI GAS CHEMICAL CO (JP) | 2019-04-03 | — | — | EP | disclosed |
| EP-3246317-A1 | BTK INHIBITOR | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. (CN) | 2017-11-22 | — | — | EP | disclosed |
| US-20170313683-A1 | BTK INHIBITOR | HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECHNOLOGICAL INSTITUTE, INC. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-4548689-A | RADICAL POLYMERIZABLE MONOMER, KETOCARBONYL COMPOUND AND MERCAPTOB | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-10-22 | — | — | US | disclosed |
| EP-0074569-B1 | CATIONIC METHINE DYES, PROCESS FOR THEIR PREPARATION AND THEIR USE, IN DYEING TEXTILE MATERIALS AND OTHER SUBSTRATES | BAYER AG (DE) | 1985-06-19 | — | — | EP | disclosed |
| US-4513142-A | Preparation of cationic methine dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1985-04-23 | — | — | US | disclosed |
| EP-0136186-A2 | Photocurable resin composition | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-04-03 | — | — | EP | disclosed |
| EP-0023991-B1 | STYRYL DYESTUFFS, THEIR PREPARATION AND THEIR USE IN DYEING PAPER IN PARTICULAR | BAYER AG (DE) | 1983-07-27 | — | — | EP | disclosed |
| EP-0074569-A2 | Cationic methine dyes, process for their preparation and their use, in dyeing textile materials and other substrates | BAYER AG (DE) | 1983-03-23 | — | — | EP | disclosed |
| US-4322487-A | Composite electrically photosensitive particles for electrophoretic migration imaging process | EASTMAN KODAK COMPANY (US) | 1982-03-30 | — | — | US | disclosed |
| EP-0023991-A1 | Styryl dyestuffs, their preparation and their use in dyeing paper in particular | BAYER AG (DE) | 1981-02-18 | — | — | EP | disclosed |
| US-4110070-A | QUATERNIZING INDOLENINE METHINE COMPOUND ON FIBERS TO FORM CATIONIC DYE | HODOGAYA CHEMICAL CO., LTD. (JP) | 1978-08-29 | — | — | US | disclosed |
| US-3975379-A | METHINE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662174-B2 | BTK inhibitor | BTK, SYK, LYN | CYP2A6 3840/4885CYP2A13 3180/4885ALDH1A1 4122/4885 |
| US-20170313683-A1 | BTK INHIBITOR | BTK, SYK, LYN | CYP2A6 3840/4885CYP2A13 3180/4885ALDH1A1 4122/4885 |
| US-20250011264-A1 | CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND | CA1, ASIC1, CA7 | CYP2A6 1236/4885CYP2A13 1771/4885ALDH1A1 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.